[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @mike98572986 mike mike posts on X about $clpt, $rgnx, rgx 121, $par the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1422364980339380240/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX +788% - X Year XXXXXXX +5,954% ### Mentions: X [#](/creator/twitter::1422364980339380240/posts_active)  - X Month XX -XX% - X Months XXX +1,505% - X Year XXX +2,119% ### Followers: XXXXX [#](/creator/twitter::1422364980339380240/followers)  - X Week XXXXX +0.69% - X Month XXXXX +6.60% - X Months XXXXX +271% - X Year XXXXX +420% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1422364980339380240/influencer_rank)  ### Social Influence **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXXX% [social networks](/list/social-networks) XXX% [technology brands](/list/technology-brands) XXX% [travel destinations](/list/travel-destinations) XXX% **Social topic influence** [$clpt](/topic/$clpt) #3, [$rgnx](/topic/$rgnx) 14.81%, [rgx 121](/topic/rgx-121) #1, [$par](/topic/$par) #34, [$qure](/topic/$qure) #7, [the first](/topic/the-first) 11.11%, [$cls](/topic/$cls) 3.7%, [prism](/topic/prism) 3.7%, [ab](/topic/ab) 3.7%, [cls](/topic/cls) XXX% **Top accounts mentioned or mentioned by** [@desertdweller93](/creator/undefined) [@micahc22](/creator/undefined) [@stockdaddy6597](/creator/undefined) [@profdollar](/creator/undefined) [@lawstudentrm](/creator/undefined) [@newinvest22](/creator/undefined) [@kane_1200](/creator/undefined) [@medstudentinvst](/creator/undefined) [@greentardscycle](/creator/undefined) [@aggie_cio](/creator/undefined) **Top assets mentioned** [Parachute (PAR)](/topic/$par) [uniQure N.V. (QURE)](/topic/$qure) [Coldstack (CLS)](/topic/$cls) [Bitcoin Incognito (XBI)](/topic/$xbi) ### Top Social Posts Top posts by engagements in the last XX hours "$clpt $rgnx RGX-121 "I am highly encouraged by the 12-month pivotal data and continued safety and efficacy profile of RGX-121" said Roberto Giugliani M.D. Ph.D. ProfessorDepartment of Genetics UFRGS Medical Genetics Service HCPAPorto Alegre Brazil."The vast majority of Hunter syndrome patients have no current treatment options to address the neurodevelopmental decline of this disease and are in urgent need of new therapies and a one-time treatment option like RGX-121 could make a meaningful impact on their lives."" [X Link](https://x.com/mike98572986/status/1963980489125220585) 2025-09-05T15:00Z 1170 followers, 2125 engagements "$par Erbert & Gerberts Transforms Operations with PARs Unified Restaurant Platform New POS payments delivery loss recovery and menu management solutions streamline complexity and boost efficiency across XX locations" [X Link](https://x.com/mike98572986/status/1991531825542602963) 2025-11-20T15:39Z 1170 followers, XXX engagements "$par is a funny one does anyone truly believe Olo was a better company than Par tech You have a recent comp Olo got bought out at X billion I dont believe Olo was anywhere near Par in the type of position they are in. Par also has a catalyst set up market gives you opportunities because they cant see past one quarter. That is all analysts care about what does the next quarter look like Its kind of cool for investors that actually can just chill and are willing to sit on their ass. Fun times" [X Link](https://x.com/mike98572986/status/1980653839511613912) 2025-10-21T15:14Z 1170 followers, 1408 engagements "$qure $clpt Staveley has not had the treatment but says that if it gets to the point she needs it and it is available she would leap at the chance: I struggle to imagine the impact this will have on my life let alone the impact on those who have already developed symptoms. I went to Hyde Park and just cried and cried Staveley recalls. For the first time I thought this is a real breakthrough. I felt I have a future. Id had this sword of Damocles over me always thinking whens the disease going to strike Staveley thought of her son Alexander known as Lexi who has just turned 11: The most" [X Link](https://x.com/mike98572986/status/1997468985521238521) 2025-12-07T00:51Z 1170 followers, 6585 engagements "$clpt rgx XXX cc $RGNX Now to RGX-121 also known as chlamidiginelamparvovec the potential first gene therapy and one-time treatment for MPS II. Our recent FDA interactions regarding the ongoing BLA have been highly productive and we remain confident in RGX-121 approval by early next year. We delivered positive 12-month data to FDA which Steve will discuss in more detail. And the FDA completed inspections of our clinical sites and in-house manufacturing facility with no observations a rare and significant achievement. These developments have further strengthened our confidence in the ongoing" [X Link](https://x.com/mike98572986/status/1987183057376628900) 2025-11-08T15:38Z 1169 followers, 1501 engagements "$clpt rgx XXX $rgnx conference today Got it. So in the last few minutes I want to touch on the Hunter Syndrome program. The FDA requested some additional information. Where are you in that process right now And do you think that's going to be a major amendment Already has been. So we were asked in our mid-cycle meeting sort of in August timeframe of last year to provide we had provided six-month data on the patients for neurocog development. And by the time we had completed the rolling VLA I think FDA looked at the dosing dates and knew we would have one year's worth of data. So we supplied" [X Link](https://x.com/mike98572986/status/1988026945616126004) 2025-11-10T23:32Z 1169 followers, 1630 engagements "$clpt rgx XXX $rgnx conference yesterday transcript This is going to be the first gene therapy for Hunter's disease and it's in a market that is completely served by enzyme replacement therapy. Even though there is an enzyme replacement therapy that's presumably in development that could cross the blood brain barrier you have the potential to potentially go in there and disrupt it. Though Denali is sitting at a $X billion valuation you guys are sitting around a $XXX million-$600 million valuation. I guess how should we think about this disconnect number one. And number two how do you think" [X Link](https://x.com/mike98572986/status/1988570293804363889) 2025-11-12T11:31Z 1169 followers, 1235 engagements "$par looks like Adam Wyden sold the heck out of par either is seeing something concerning or wanted to be more diversified" [X Link](https://x.com/mike98572986/status/1989460271593918622) 2025-11-14T22:27Z 1169 followers, 1366 engagements "$clpt minute XX same delivery on all programs AS first patient dosed last week. If Rgx XXX gets approved in February makes all these programs a lot more attractive from there" [X Link](https://x.com/mike98572986/status/1990577011010711726) 2025-11-18T00:25Z 1169 followers, 2067 engagements "@lawstudent_RM nice find $clpt $CLS Clinical Laserthermia Systems AB (publ) (CLS) today announces that it has formally applied for CE marking of its ClearPoint Prism branded Neuro Laser Therapy System seeking regulatory approval in Europe for use with 1.5T and 3.0T magnetic resonance imaging (MRI) guidance in neurosurgical procedures" [X Link](https://x.com/mike98572986/status/1996130829446381697) 2025-12-03T08:14Z 1169 followers, XXX engagements "Post on LinkedIn from Ian Laquian Not directly related to clearpoint $clpt in either study or trial but the conclusion is Justone weekafter Novo Nordisk ended their Alzheimers trial with negative results researchers at Imperial College London published inNature Medicine showing the exact opposite: #Liraglutide a once-daily injectable GLP-1 SLOWED COGNITIVE DECLINE AND PRESERVED BRAIN VOLUME The starkly different results provide food for thought as both drugs target the same GLP-1 pathway but differ in: Formulation:Liraglutide injectable vs. Semaglutide oral Molecular size:Liraglutides short" [X Link](https://x.com/mike98572986/status/1996143286277571065) 2025-12-03T09:03Z 1170 followers, 1151 engagements "If These quotes are true VP might not be the problem very odd public statements if these are his true thoughts. If these are true I dont believe he is going to ask for a whole new trial $qure $clpt" [X Link](https://x.com/mike98572986/status/1996957899164426541) 2025-12-05T15:00Z 1170 followers, 3506 engagements "$qure $clpt What a odd situation this has been on one hand Makary and VP sound rational and good for gene therapies on their public statements seems their words have been hot air mostly actions havent really held up on the other hand if they get fired you also have to ask who is next. At this point I guess you take your chance with some new characters. I do wish we had more insight on what the fda is saying to Uniqure because if the hold up is just they want more patients at the X year and X year mark that isnt really a irrational thing. I havent been a fan of VP but his point about trying to" [X Link](https://x.com/mike98572986/status/1997114940776456241) 2025-12-06T01:24Z 1170 followers, 3166 engagements "@micahc22 @StockDaddy6597 RGX-121 and KEBILIDI" [X Link](https://x.com/mike98572986/status/1997685022657278346) 2025-12-07T15:09Z 1170 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@mike98572986 mike
mike posts on X about $clpt, $rgnx, rgx 121, $par the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +788%
- X Year XXXXXXX +5,954%
Mentions: X #
- X Month XX -XX%
- X Months XXX +1,505%
- X Year XXX +2,119%
Followers: XXXXX #
- X Week XXXXX +0.69%
- X Month XXXXX +6.60%
- X Months XXXXX +271%
- X Year XXXXX +420%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence cryptocurrencies XXXXX% social networks XXX% technology brands XXX% travel destinations XXX%
Social topic influence $clpt #3, $rgnx 14.81%, rgx 121 #1, $par #34, $qure #7, the first 11.11%, $cls 3.7%, prism 3.7%, ab 3.7%, cls XXX%
Top accounts mentioned or mentioned by @desertdweller93 @micahc22 @stockdaddy6597 @profdollar @lawstudentrm @newinvest22 @kane_1200 @medstudentinvst @greentardscycle @aggie_cio
Top assets mentioned Parachute (PAR) uniQure N.V. (QURE) Coldstack (CLS) Bitcoin Incognito (XBI)
Top Social Posts
Top posts by engagements in the last XX hours
"$clpt $rgnx RGX-121 "I am highly encouraged by the 12-month pivotal data and continued safety and efficacy profile of RGX-121" said Roberto Giugliani M.D. Ph.D. ProfessorDepartment of Genetics UFRGS Medical Genetics Service HCPAPorto Alegre Brazil."The vast majority of Hunter syndrome patients have no current treatment options to address the neurodevelopmental decline of this disease and are in urgent need of new therapies and a one-time treatment option like RGX-121 could make a meaningful impact on their lives.""
X Link 2025-09-05T15:00Z 1170 followers, 2125 engagements
"$par Erbert & Gerberts Transforms Operations with PARs Unified Restaurant Platform New POS payments delivery loss recovery and menu management solutions streamline complexity and boost efficiency across XX locations"
X Link 2025-11-20T15:39Z 1170 followers, XXX engagements
"$par is a funny one does anyone truly believe Olo was a better company than Par tech You have a recent comp Olo got bought out at X billion I dont believe Olo was anywhere near Par in the type of position they are in. Par also has a catalyst set up market gives you opportunities because they cant see past one quarter. That is all analysts care about what does the next quarter look like Its kind of cool for investors that actually can just chill and are willing to sit on their ass. Fun times"
X Link 2025-10-21T15:14Z 1170 followers, 1408 engagements
"$qure $clpt Staveley has not had the treatment but says that if it gets to the point she needs it and it is available she would leap at the chance: I struggle to imagine the impact this will have on my life let alone the impact on those who have already developed symptoms. I went to Hyde Park and just cried and cried Staveley recalls. For the first time I thought this is a real breakthrough. I felt I have a future. Id had this sword of Damocles over me always thinking whens the disease going to strike Staveley thought of her son Alexander known as Lexi who has just turned 11: The most"
X Link 2025-12-07T00:51Z 1170 followers, 6585 engagements
"$clpt rgx XXX cc $RGNX Now to RGX-121 also known as chlamidiginelamparvovec the potential first gene therapy and one-time treatment for MPS II. Our recent FDA interactions regarding the ongoing BLA have been highly productive and we remain confident in RGX-121 approval by early next year. We delivered positive 12-month data to FDA which Steve will discuss in more detail. And the FDA completed inspections of our clinical sites and in-house manufacturing facility with no observations a rare and significant achievement. These developments have further strengthened our confidence in the ongoing"
X Link 2025-11-08T15:38Z 1169 followers, 1501 engagements
"$clpt rgx XXX $rgnx conference today Got it. So in the last few minutes I want to touch on the Hunter Syndrome program. The FDA requested some additional information. Where are you in that process right now And do you think that's going to be a major amendment Already has been. So we were asked in our mid-cycle meeting sort of in August timeframe of last year to provide we had provided six-month data on the patients for neurocog development. And by the time we had completed the rolling VLA I think FDA looked at the dosing dates and knew we would have one year's worth of data. So we supplied"
X Link 2025-11-10T23:32Z 1169 followers, 1630 engagements
"$clpt rgx XXX $rgnx conference yesterday transcript This is going to be the first gene therapy for Hunter's disease and it's in a market that is completely served by enzyme replacement therapy. Even though there is an enzyme replacement therapy that's presumably in development that could cross the blood brain barrier you have the potential to potentially go in there and disrupt it. Though Denali is sitting at a $X billion valuation you guys are sitting around a $XXX million-$600 million valuation. I guess how should we think about this disconnect number one. And number two how do you think"
X Link 2025-11-12T11:31Z 1169 followers, 1235 engagements
"$par looks like Adam Wyden sold the heck out of par either is seeing something concerning or wanted to be more diversified"
X Link 2025-11-14T22:27Z 1169 followers, 1366 engagements
"$clpt minute XX same delivery on all programs AS first patient dosed last week. If Rgx XXX gets approved in February makes all these programs a lot more attractive from there"
X Link 2025-11-18T00:25Z 1169 followers, 2067 engagements
"@lawstudent_RM nice find $clpt $CLS Clinical Laserthermia Systems AB (publ) (CLS) today announces that it has formally applied for CE marking of its ClearPoint Prism branded Neuro Laser Therapy System seeking regulatory approval in Europe for use with 1.5T and 3.0T magnetic resonance imaging (MRI) guidance in neurosurgical procedures"
X Link 2025-12-03T08:14Z 1169 followers, XXX engagements
"Post on LinkedIn from Ian Laquian Not directly related to clearpoint $clpt in either study or trial but the conclusion is Justone weekafter Novo Nordisk ended their Alzheimers trial with negative results researchers at Imperial College London published inNature Medicine showing the exact opposite: #Liraglutide a once-daily injectable GLP-1 SLOWED COGNITIVE DECLINE AND PRESERVED BRAIN VOLUME The starkly different results provide food for thought as both drugs target the same GLP-1 pathway but differ in: Formulation:Liraglutide injectable vs. Semaglutide oral Molecular size:Liraglutides short"
X Link 2025-12-03T09:03Z 1170 followers, 1151 engagements
"If These quotes are true VP might not be the problem very odd public statements if these are his true thoughts. If these are true I dont believe he is going to ask for a whole new trial $qure $clpt"
X Link 2025-12-05T15:00Z 1170 followers, 3506 engagements
"$qure $clpt What a odd situation this has been on one hand Makary and VP sound rational and good for gene therapies on their public statements seems their words have been hot air mostly actions havent really held up on the other hand if they get fired you also have to ask who is next. At this point I guess you take your chance with some new characters. I do wish we had more insight on what the fda is saying to Uniqure because if the hold up is just they want more patients at the X year and X year mark that isnt really a irrational thing. I havent been a fan of VP but his point about trying to"
X Link 2025-12-06T01:24Z 1170 followers, 3166 engagements
"@micahc22 @StockDaddy6597 RGX-121 and KEBILIDI"
X Link 2025-12-07T15:09Z 1170 followers, XX engagements